Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Corporation

The latest update is out from Phibro Animal Health ( ($PAHC) ). On February 3, 2026, Phibro Animal Health Corporation’s board declared a quarterly ...

Current Quarter	$0.69	Next Quarter	$0.69
Current Year	$2.76	Next Year	$2.94
QoQ Growth	+0.0%	YoY Growth	+6.5%
3Y EPS CAGR	-0.5%	Target Price	$41.00
Consensus	Buy	Upside	-0.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PAHC	$41.03	-2.10%	206.70K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PAHC	$41.03	-2.1%	206.70K
3
4
5
6

PAHC

PAHC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Phibro Animal Health Corporation Data in Excel

Get Phibro Animal Health Corporation Data in Excel